Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IMMUNOe has been conducting clinical research since at least the late '90s with a strong reputation among major pharmaceutical sponsors. They have participated in over 250 clinical trials under the leadership of Dr. Isaac Melamed. Their work spans allergy/immunology to neurology and rare immune disorders. They are recognized for expertise in managing complex immune-related trial operations and patient care but do not develop proprietary therapeutics themselves—they serve as a CRO/research center partner to industry sponsors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IMMUNOe Health & Research Centers.